

A lung nodule is a small, usually round or oval area seen within the lung on imaging tests. It is often discovered incidentally during a chest X-ray or computed tomography (CT) scan performed for another reason.
Finding a lung nodule does not automatically mean lung cancer. Previous infections, scar tissue, benign tumors, inflammatory conditions, and several other causes may also produce a nodular appearance in the lungs.
However, certain imaging features, growth over time, and individual risk factors may make further evaluation necessary.
The main goal in lung nodule assessment is not to operate on every nodule, but to determine which nodules can be safely monitored and which require additional investigation.
A lung nodule is a localized area of increased density within the lung tissue. On CT imaging, it appears different from the surrounding normal lung.
Lung nodules may:
The diameter of the nodule is important, but its structure and changes over time are equally relevant.
Lung nodules may develop for many different reasons.
Some of the more common causes include:
Tuberculosis, certain fungal infections, and other previous lung infections may leave small areas of scar tissue after healing.
These areas may appear as nodules on CT scans.
Granulomas are small inflammatory structures that may form as part of the body’s response to certain infections or inflammatory processes.
Many granulomas are benign.
Benign tumors such as hamartomas may also appear as lung nodules.
Certain autoimmune, rheumatological, or inflammatory diseases may cause nodular changes in the lungs.
Some lung cancers may first appear as a small lung nodule, particularly in the early stages.
For this reason, nodules with suspicious imaging characteristics require careful assessment.
In patients with a previous history of cancer elsewhere in the body, some lung nodules may represent metastatic disease.
Even in this situation, however, imaging alone is not always sufficient to establish a definite diagnosis.
Not every lung nodule is dangerous.
A considerable proportion of lung nodules are caused by benign conditions. However, certain features may increase the possibility that a nodule is malignant.
Evaluation usually considers factors such as:
Two patients with nodules of the same size may therefore require very different management plans.
Nodule size is one of the main factors considered during assessment.
In general, very small nodules tend to have a lower likelihood of malignancy. As a nodule becomes larger or develops certain suspicious imaging features, closer follow-up or further testing may be considered.
However, surgery is never determined by diameter alone.
For example, a small nodule with irregular borders or documented growth may require closer evaluation, while a larger nodule that has remained unchanged for years and has benign imaging characteristics may be managed differently.
Most lung nodules do not cause symptoms.
They are frequently discovered incidentally during a chest X-ray or CT scan performed for another reason.
In some cases, symptoms may be related to the underlying condition rather than the nodule itself.
These symptoms may include:
However, these symptoms are not specific to lung nodules and may occur in many other conditions.
When a lung nodule is detected, the first step is usually a detailed evaluation of its imaging characteristics and the patient’s clinical background.
Current CT images may also be compared with previous scans.
Determining whether the nodule has remained stable over months or years can provide important information.
Depending on the individual case, evaluation may include the following methods.
CT imaging is used to assess the size, shape, density, borders, and location of the nodule in detail.
Previous imaging studies can be particularly valuable.
A nodule that has increased in size over time may require a different approach from one that has remained unchanged.
PET-CT may be used in selected cases to evaluate the metabolic activity of a lung nodule.
However, PET-CT cannot by itself confirm cancer.
Inflammatory and infectious conditions may also show increased metabolic activity, while some small or slow-growing cancers may show little or no significant uptake.
Depending on the size and location of the nodule, tissue sampling may be performed through bronchoscopy or image-guided needle biopsy.
Biopsy is not equally suitable for every nodule.
In selected cases, surgical removal of the nodule may be considered both for diagnosis and treatment.
For many low-risk lung nodules, surgery is not the first step.
Instead, the nodule may be monitored with follow-up CT scans at planned intervals.
The timing and duration of follow-up depend on factors such as:
The aim is to avoid unnecessary invasive procedures while still identifying significant changes at an appropriate stage.
Growth during follow-up is an important finding.
However, enlargement does not automatically mean cancer.
Some infectious and inflammatory nodules may also change in size.
For this reason, the rate of growth, internal structure, borders, and other imaging characteristics are assessed together.
If the level of concern increases, PET-CT, biopsy, or surgical evaluation may be considered.
The decision to perform a biopsy is individualized.
A biopsy may be considered when:
Needle biopsy is not always possible or appropriate.
Very small nodules, difficult anatomical locations, or nearby structures may affect both the safety and diagnostic accuracy of the procedure.
The presence of a lung nodule alone is not an indication for surgery.
Surgical evaluation may become appropriate when:
Before surgery, the patient’s general health, lung function, and ability to tolerate an operation are also assessed.
The type of surgery depends on the size and location of the nodule, the suspected diagnosis, and the patient’s overall condition.
A wedge resection removes a small, wedge-shaped portion of lung tissue containing the nodule.
It may be used for diagnostic purposes or in selected small lesions.
A segmentectomy removes one anatomical segment of a lung lobe.
It may be considered in selected early-stage lung cancers or for lesions in suitable locations.
A lobectomy involves removal of one of the lobes of the lung.
It remains an important surgical option for selected patients with early-stage lung cancer.
The most appropriate operation is determined according to the pathology, location of the lesion, stage of disease, and the patient’s pulmonary reserve.
In suitable patients, lung nodules may be removed using minimally invasive surgical techniques.
Video-assisted thoracoscopic surgery, known as VATS, is performed through small incisions using a camera and specialized surgical instruments rather than a large thoracic incision.
Robotic thoracic surgery may also be used in selected patients.
However, minimally invasive surgery is not suitable for every patient or every type of nodule.
The location and size of the lesion, its relationship with surrounding structures, and the planned extent of resection all influence the choice of surgical approach.
There is no single answer to this question.
Nodules considered likely to be benign and that remain stable over time may only require follow-up.
On the other hand, delaying the evaluation of a highly suspicious nodule may result in a possible lung cancer being diagnosed at a later stage.
The correct approach is therefore not to operate on every nodule or ignore every nodule, but to choose a management strategy based on the individual level of risk.
When lung cancer is detected at an early stage before it has spread beyond the lung, the available treatment options may be significantly different.
Surgery may be an option for selected patients with early-stage lung cancer.
For this reason, appropriate follow-up and timely investigation of suspicious nodules are important.
At the same time, it is equally important not to assume that every lung nodule represents cancer.
Evaluation of lung nodules may involve several specialties, including radiology, pulmonology, thoracic surgery, nuclear medicine, and pathology.
Thoracic surgical assessment may become particularly relevant when:
The specialties involved depend on the individual patient’s findings.
No.
Lung nodules may develop for many different reasons, and a substantial number are benign.
However, some nodules can represent an early sign of lung cancer.
The appropriate approach is therefore neither to ignore the finding nor to assume the worst immediately.
A structured assessment based on imaging characteristics, changes over time, and individual risk factors provides the most appropriate basis for further management.
No. Many lung nodules are caused by benign conditions such as previous infections, granulomas, or benign tumors. The likelihood of cancer is assessed according to the nodule’s features and the patient’s individual risk factors.
Some nodules related to infection or inflammation may become smaller or disappear over time. Others may remain unchanged for many years.
There is no single size that automatically makes a nodule dangerous. Larger size may increase concern, but shape, density, growth pattern, and individual risk factors are also important.
The growth rate depends on the underlying cause. Comparison with previous CT scans is therefore an important part of evaluation.
Small lung nodules usually do not cause pain and are often discovered incidentally.
No. PET-CT is not required for every nodule. Its use depends on the size, imaging appearance, and estimated level of risk.
Not always. Biopsy can provide important diagnostic information, but obtaining sufficient tissue may be difficult in some nodules depending on their size and location.
Yes, in selected patients. VATS or robotic thoracic surgery may be suitable depending on the location of the nodule and the planned operation.
Yes. Lung nodules are not limited to people who smoke. Infections, inflammation, benign tumors, and other conditions may also cause nodules in non-smokers.
There is no universal follow-up interval. The timing depends on the size, type, imaging characteristics, previous changes, and individual risk factors.
This content is intended for general informational purposes only. The evaluation of a lung nodule depends on its size, imaging characteristics, changes on previous scans, and the patient’s medical history. The information provided here does not replace individual medical assessment, diagnosis, or treatment planning. The need for follow-up, biopsy, or surgery should be determined on a case-by-case basis.